ストックスクリーナーアプリを入手
22.69
0.35%
0.08
アフターアワーズ：
22.69
前日終値:
$22.61
開ける：
$22.71
24時間の取引高:
622.55K
Relative Volume:
2.32
時価総額：
$582.87M
収益：
-
当期純損益:
$11.77M
株価収益率:
39.22
EPS:
0.5785
ネットキャッシュフロー:
$-19.23M
1週間 パフォーマンス:
+20.31%
1か月 パフォーマンス:
+37.18%
6か月 パフォーマンス:
+38.95%
1年 パフォーマンス:
+39.20%
1日の値動き範囲:
$21.49
$23.70
1週間の範囲:
$18.32
$23.70
52週間の値動き範囲:
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
TRML を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
22.69 | 580.82M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-23 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-06 | 開始されました | Wedbush | Outperform |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-12-15 | 開始されました | Jefferies | Buy |
| 2023-12-04 | 再開されました | H.C. Wainwright | Buy |
| 2023-11-17 | 開始されました | Truist | Buy |
| 2023-10-31 | 開始されました | Guggenheim | Buy |
| 2023-10-25 | 開始されました | Piper Sandler | Overweight |
| 2022-10-20 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
すべてを表示
Tourmaline Bio Inc (TRML) 最新ニュース
Does Tourmaline Bio Inc. stock perform well during market downturnsExplosive trading opportunities - jammulinksnews.com
Is Tourmaline Bio Inc. a candidate for recovery playDaily Upside Movement Prediction With Data - Newser
What catalysts could drive Tourmaline Bio Inc. stock higher in 2025Free Consultation - jammulinksnews.com
Building trade automation scripts for Tourmaline Bio Inc.Free Pattern Detection for Entry Confirmation - Newser
Analyzing Tourmaline Bio Inc. with multi timeframe chartsEntry Optimization Tool with Screener Logic - Newser
New York State Common Retirement Fund Sells 3,200 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
What are analysts’ price targets for Tourmaline Bio Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com
When is Tourmaline Bio Inc. stock expected to show significant growthUnlock steady growth with low-risk stocks - jammulinksnews.com
How does Tourmaline Bio Inc. generate profit in a changing economyTrack stocks with high upside potential easily - jammulinksnews.com
What are the latest earnings results for Tourmaline Bio Inc.Free AI-Backed Trading Signals - jammulinksnews.com
Should I hold or sell Tourmaline Bio Inc. stock in 2025Get exclusive market insights for better trading - jammulinksnews.com
Is Tourmaline Bio Inc. a Top Dividend Stock to Watch in 2025Free Signals Group - metal.it
What are Tourmaline Bio Inc. company’s key revenue driversUnlock powerful trading tools for investors - jammulinksnews.com
How strong is Tourmaline Bio Inc. company’s balance sheetInvest smarter with expert stock recommendations - jammulinksnews.com
What makes Tourmaline Bio Inc. stock price move sharplyTurn market volatility into profit opportunities - jammulinksnews.com
Tourmaline Bio Inc. Company Revenue and Profit Trends: A Deep DiveReturn Maximized Portfolio Strategy - Newser
New Product Launches: Will They Boost Tourmaline Bio Inc. Stock in 2025Free Consultation - Newser
Intrinsic Value of Tourmaline Bio Inc. Stock: Is It Undervalued or OvervaluedParabolic Move Ideas - Newser
Is Tourmaline Bio Inc. stock a good hedge against inflationFree Stock Tips Group - Newser
Is Tourmaline Bio Inc. Stock Overbought or Oversold RSI Indicator Analysis - Newser
Why Tourmaline Bio Inc. stock is on top investor watchlistsFree Investment Timing Strategies - jammulinksnews.com
Tourmaline Bio to Present Topline Results From the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025 - 富途牛牛
Analysts Are Bullish on Top Healthcare Stocks: HOYA (HOCPF), Align Tech (ALGN) - The Globe and Mail
Tourmaline Bio Inc. Stock Analysis and ForecastHigh-yield market plays - jammulinksnews.com
What analysts say about Tourmaline Bio Inc. stockDouble-digit growth - Autocar Professional
Is Tourmaline Bio Inc. a good long term investmentExceptional gains - Autocar Professional
What drives Tourmaline Bio Inc. stock priceMarket-leading profit generation - jammulinksnews.com
What drives SuRo Capital Corp. stock priceRapid wealth multiplication - jammulinksnews.com
Tourmaline Bio Inc (TRML) 財務データ
収益
当期純利益
現金流量
EPS
10.28%
2.59%
大文字化:
|
ボリューム (24 時間):